Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Pirlimycin hydrochloride | 78822-40-9 | MFCD27952783 | 99.1% | 447.42 g·mol⁻¹ | C17H32Cl2N2O5S | 1 MG
SDP

Catalog No. 5000240522
Encompass_Preferred

Pirlimycin hydrochloride is a lincosamide-class antibiotic supplied as the hydrochloride salt for research use. It inhibits bacterial protein synthesis by binding the 50S ribosomal subunit and is primarily active against Gram-positive organisms. The material is provided as a solid at high purity for analytical and laboratory applications.

  • Lincosamide antibiotic.
  • Inhibits bacterial protein synthesis via 50S ribosomal binding.
  • Primarily active against Gram-positive bacteria.
  • High purity (99.1%).
  • Supplied as a solid suitable for analytical use.
  • Available in small-scale quantities for research.

Catalog No. 50-002-40522 Supplier Medchemexpress LLC Supplier No. HY106597A1MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pirlimycin hydrochloride is a lincosamide-class antibiotic supplied as the hydrochloride salt for research use. It inhibits bacterial protein synthesis by binding the 50S ribosomal subunit and is primarily active against Gram-positive organisms. The material is provided as a solid at high purity for analytical and laboratory applications.

  • Lincosamide antibiotic.
  • Inhibits bacterial protein synthesis via 50S ribosomal binding.
  • Primarily active against Gram-positive bacteria.
  • High purity (99.1%).
  • Supplied as a solid suitable for analytical use.
  • Available in small-scale quantities for research.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.